EGFR and neoplasm: With ability to bind specifically to EGFR-upregulated cells in tumor tissues, GE11-mediated delivery of therapeutic cargoes proceeds without activating the EGF-receptor [168], and thus, this method of delivery appears to be appropriate for treating different types of cancers [247].